C Ghilardi1, M R Bani, R Giavazzi. Show Affiliations » 1. Laboratory of the Biology and Treatment of Metastasis, Mario Negri Institute for Pharmacological Research, Bergamo, Italy.
Abstract
Mesh： See more » Angiogenesis Inhibitors/pharmacologyAngiogenesis Inhibitors/therapeutic useAnimalsAntineoplastic Agents/pharmacologyAntineoplastic Agents/therapeutic useAntineoplastic Combined Chemotherapy Protocols/pharmacologyClinical Trials as TopicEndothelial Growth Factors/antagonists & inhibitorsHumansLymphokines/antagonists & inhibitorsMetalloendopeptidases/antagonists & inhibitorsNeoplasms/blood supplyNeoplasms/drug therapyNeovascularization, Pathologic/drug therapyNeovascularization, Pathologic/prevention & controlReceptor Protein-Tyrosine Kinases/antagonists & inhibitorsReceptors, Growth Factor/antagonists & inhibitorsReceptors, Vascular Endothelial Growth FactorTreatment OutcomeVascular Endothelial Growth Factor AVascular Endothelial Growth Factors
Substances： See more » Angiogenesis InhibitorsAntineoplastic AgentsEndothelial Growth FactorsLymphokinesReceptors, Growth FactorVascular Endothelial Growth Factor AVascular Endothelial Growth FactorsReceptor Protein-Tyrosine KinasesReceptors, Vascular Endothelial Growth FactorMetalloendopeptidases
Year: 2001 PMID： 11989610
Source DB: PubMed Journal: Tumori ISSN： 0300-8916 Impact factor: 2.098